Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

SKB reports fibrinogen antagonists

Aug. 16, 1996

Anticoagulant hirudin analogue NF-22 designated developmental candidate

Aug. 16, 1996

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Ortho reveals fibrinogen antagonists

Aug. 9, 1996

Bicyclic fibrinogen antagonists described by SmithKline Beecham

Aug. 9, 1996

Piperazine fibrinogen antagonists from Thomae

Aug. 9, 1996

RO-11 demonstrates efficacy in phase III as DVT prevention agent

Aug. 9, 1996

Thrombin inhibitors inhelabo's pipeline

Aug. 9, 1996

RPR's enoxaparin reduces risk of DVT following hip replacement

Aug. 9, 1996

Hemaseel HMN phase I results announced

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026